Td Private Client Wealth LLC Axsome Therapeutics, Inc. Transaction History
Td Private Client Wealth LLC
- $3.63 Trillion
- Q1 2025
A detailed history of Td Private Client Wealth LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 14 shares of AXSM stock, worth $1,549. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14Holding current value
$1,549% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
409Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$429 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$365 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$323 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$187 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$108 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.74B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...